Opinion: Battling Cancer, and FDA Bureaucrats

January 31, 2020

By Robert Goldberg

For some patients with advanced breast cancer, 2011 began with a harrowing close call: A federal contractor announced that Medicare would no longer pay for women in several states to receive treatment with the drug Avastin.

A Fighting Spirit Won’t Save Your Life

January 30, 2020

By Richard Stone Op Editor NYT

GABRIELLE GIFFORDS’S remarkable recovery from a bullet to her head has provided a heartening respite from a national calamity. Representative Giffords’s husband describes her as a “fighter,” and no doubt she is one. Whether her recovery has anything to do with a fighting spirit, however, is another matter entirely.

Do Emotions Play a Role in Illness?

January 29, 2020

By New York Times Letters to the Editor

Support groups prolong survival in women with metastatic breast cancer.

Abrupt Turnabout in Fortunes of PARP Inhibitor

January 28, 2020

By Charles Bankhead

A highly touted investigational breast cancer therapy failed to extend survival in women with metastatic triple-negative disease, according to final results from a large phase III trial.

Vinorelbine 'Preferred' Chemo in HER2-Positive Advanced Breast Cancer

January 28, 2020

By Nick Mulcahy

What's the best chemotherapy to use in combination with trastuzumab in women with HER2-positive metastatic and locally advanced breast cancer?

"Race for the Cure" brand battle courts controversy

January 27, 2021

By Anne Thompson, NBC Nightly News

Susan G Komen Race for the Cure, one of the country's largest and best funded breast cancer charities, is being questioned about its agressive tactics when it comes to protecting its trademark.

ASCO GI: Rethink Views On Breast CA Liver Mets

January 24, 2021

By Charles Bankhead

Resection of breast cancer liver metastases paid off in a survival benefit in patients with chemotherapy-responsive, estrogen receptor (ER)-positive primary tumors, according to data from a retrospective chart review.

Eisai's Halaven(TM) (Eribulin) Receives CHMP Positive Opinion for use in Metastatic Breast Cancer

January 21, 2021

By PR Newswire

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), today gave a positive opinion for the use of Eisai Europe, Ltd.'s Halaven as a monotherapy indicated in the treatment of patients with locally advanced (LA) or metastatic breast cancer (MBC) who have progressed after at least two chemotherapeutic regimens for advanced disease.

Bevacizumab in Breast Cancer: Genentech Submits Response to FDA

January 20, 2021

By Zosia Chustecka

Genentech, the manufacturer of bevacizumab (Avastin), submitted a response to the US Food and Drug Administration (FDA) today on the agency's proposal to withdraw the drug's breast cancer indication.

A Pink-Ribbon Race, Years Long

January 18, 2021

By Roni Caryn Rabin, New York Times

By the time Suzanne Hebert realized that her doctor was wrong and that the hard lump in her breast wasn’t a normal part of breast-feeding, the tumor was the size of a stopwatch and the cancer had spread to her spine.